Yesterday we had the pleasure to welcome our potential partners Agmar together with five key opinion leaders from Croatia for an intensive two-day visit.
After testing ChemoMaker at Biovalley, today they visited the Centro di Riferimento Oncologico IRCCS, where they could see the system in real hospital operation.
The feedback has been extremely positive, and we’re confident that Croatia could soon join the growing list of EU countries where our technology supports safer and more efficient oncology treatments.
A heartfelt thank you to the Agmar team and to all the professionals involved for their time, expertise, and enthusiasm! 🌍💪